Mold-Tek Packaging Limited has informed the Exchange regarding 'Updates'.
MOLDTKPAC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Mold-Tek Packaging reported strong FY 2025-26 results with revenue growing 13.48% to ₹886.61 crores from ₹781.32 crores. PAT increased 20.35% to ₹72.87 crores, while EBITDA rose 20.59% to approximately ₹217.35 crores. Sales volumes grew 11.39% to 42,629 MT. The standout performer was the Pharma Packs segment with volume growth of 208.96%, reaching a projected turnover of ₹35 crores. The company consolidated its Hyderabad manufacturing from 5 units to 2, which management expects to yield full operational and financial benefits from FY 2026-27. Statutory auditors M. Anandam & Co. issued an unmodified (clean) opinion on the financial statements, and no going concern or qualification issues were raised. The Board also declared an interim dividend of ₹2.00 per share (40% on face value of ₹5).
The company delivered robust double-digit growth in both revenue and profitability, with EBITDA margin expansion driving PAT growth of over 20%. The clean audit opinion, strong segmental performance particularly in pharma, and manufacturing consolidation all signal positive momentum heading into FY 2026-27 where management targets crossing ₹1,000 crores in turnover.